Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/21/1998 | EP0872447A1 Silicon oxide powder and process for the production thereof, cosmetics made by using the same, micelle-retaining powder, and perfume-retaining powder |
10/21/1998 | EP0872249A1 Gene transfer preparation |
10/21/1998 | EP0872247A1 Pharmaceutical formulation |
10/21/1998 | EP0872244A1 Cosmetic or pharmaceutical composition containing an Andiroba extract |
10/21/1998 | EP0872243A1 Herb composition, herbal paste and herbal plaster made from the same |
10/21/1998 | EP0872242A2 A coated sodium phosphate bowel cleanser |
10/21/1998 | EP0872241A2 Calcium carbonate liquid antacid compositions |
10/21/1998 | EP0872240A1 Solid preparation from vitamins and calcium, its manufacturing process and use |
10/21/1998 | EP0872236A1 Eye drops |
10/21/1998 | EP0872234A2 Laminar medical formulation |
10/21/1998 | EP0872233A1 Antiretroviral compositions with improved bioavailability |
10/21/1998 | EP0872232A1 Pharmaceutical preparation with delayed release of active ingredient |
10/21/1998 | EP0872231A1 Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration |
10/21/1998 | EP0871758A1 Liposomal transfection method |
10/21/1998 | EP0871714A1 Method for solubilizing proteins in organic solvents |
10/21/1998 | EP0871491A2 Polymers |
10/21/1998 | EP0871489A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
10/21/1998 | EP0871476A1 Dried blood factor composition comprising trehalose |
10/21/1998 | EP0871467A1 Novel formulation for peptide release |
10/21/1998 | EP0871450A1 New combination |
10/21/1998 | EP0871437A1 Use of boswellic acid for treating brain tumours |
10/21/1998 | EP0871435A1 Sustained release formulation containing three different types of polymers |
10/21/1998 | EP0871434A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
10/21/1998 | EP0871433A2 Composition for sustained release of non-aggregated erythropoietin |
10/21/1998 | EP0871432A2 Biological agent compositions |
10/21/1998 | EP0871431A2 Hepatocyte-selective oil-in-water emulsion |
10/21/1998 | EP0871430A1 Improvements in and relating to powders for use in dry powder inhalers |
10/21/1998 | EP0871428A1 Preparation used in dental care |
10/21/1998 | EP0871420A1 Triacetin as a transdermal penetration enhancer |
10/21/1998 | EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
10/21/1998 | CN1196682A O/W emulsion composition for eye drops |
10/21/1998 | CN1196677A Process for preparing solid bosage forms of very low-dose drugs |
10/21/1998 | CN1196676A Ophthalamic compositions containing cyclotextrins and quatemary ammonium composition |
10/21/1998 | CN1196262A Formula of relieving asthma pill and preparation technology thereof |
10/21/1998 | CN1196254A Pill for treating arthritis and its compounding method |
10/21/1998 | CN1196250A Health-care cigarette with medicinal function |
10/21/1998 | CN1196243A Powder agent formula for treating acne and seborrhea and preparation method |
10/21/1998 | CN1196242A Four-in-one ointment for gynaecology external use |
10/21/1998 | CN1196240A Heme antianemia medicine and preparation method |
10/21/1998 | CN1196239A Skin permeation medicinal control release paster for give-up drug |
10/21/1998 | CN1196238A Water-in-oil emulsions based on two specific emulsifiers and cosmetic applications |
10/20/1998 | US5824812 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes |
10/20/1998 | US5824685 Vision defects and gene expression |
10/20/1998 | US5824668 Steroid and cyclodextrin used to treat obesity, diabetes, hpercorticoidism, anemia |
10/20/1998 | US5824666 Low PH, hydrolytically stable, cosmetic compositions containing acidic actives |
10/20/1998 | US5824658 Topical composition containing hyaluronic acid and NSAIDS |
10/20/1998 | US5824646 Administering calcitonin in combinatin with an adhesion promoter consisting of a nonionic surfactant and saturated aliphatic carboxylic acid |
10/20/1998 | US5824638 Oral insulin delivery |
10/20/1998 | US5824345 Microsphere comprising active agent, proteinoid, modified hydrolyzed vegetable protein |
10/20/1998 | US5824344 Blending omoxacillin with glyceryl behenate, compaction, milling, screening and thermal infusion |
10/20/1998 | US5824343 Bioerodible polymers, compositions and therapeutic method |
10/20/1998 | US5824342 Flash flow formed solloid delivery systems |
10/20/1998 | US5824341 Composition providing selective release of an active ingredient |
10/20/1998 | US5824340 Ruminal drug delivery device |
10/20/1998 | US5824339 Effervescent composition and its production |
10/20/1998 | US5824338 Caplet and gelatin covering therefor |
10/20/1998 | US5824337 Synthetic membranes forming micelles and micelle-like structures comprising lipo-glycoprotein membranes |
10/20/1998 | US5824336 Chewable flubendazole tablets for companion animals |
10/20/1998 | US5824331 Bioartificial devices and cellular matrices therefor |
10/20/1998 | US5824072 Biocompatible ocular implants |
10/20/1998 | US5823983 Bandages comprising compressed cellulose |
10/20/1998 | CA2146565C Compositions for treatment of inflamed tissues |
10/20/1998 | CA2126200C Prolamine coatings for taste-masking orally-administrable medicaments |
10/20/1998 | CA2103163C Compositions and methods for the sublingual or buccal administration of therapeutic agents |
10/20/1998 | CA2066924C Use of lysine pyrrolidonecarboxylate and(or) arginine pyrrolidonecarboxylate as an antioxidant in pharmaceutical or cosmetic composition |
10/15/1998 | WO1998045463A1 Composition for gene introduction into cell |
10/15/1998 | WO1998045322A2 Diagnosis method and reagents |
10/15/1998 | WO1998045317A1 Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules |
10/15/1998 | WO1998045250A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
10/15/1998 | WO1998044950A1 Therapeutic material for periodontosis |
10/15/1998 | WO1998044949A1 Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters |
10/15/1998 | WO1998044937A1 Preventive or remedy for kidney diseases |
10/15/1998 | WO1998044933A1 Phosphate-binding polymer preparations |
10/15/1998 | WO1998044912A1 Adherent microcapsules containing biologically active ingredients |
10/15/1998 | WO1998044911A1 Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same |
10/15/1998 | WO1998044909A1 Improved methods of delivery using cationic lipids and helper lipids |
10/15/1998 | WO1998044896A1 Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin |
10/15/1998 | WO1998044895A2 Cosmetic and dermatological agent with a hard-magnetic particle base |
10/15/1998 | WO1998044884A2 Vaginal tampon and process for producing the same |
10/15/1998 | WO1998029134A3 Microporation of tissue for delivery of bioactive agents |
10/15/1998 | WO1998029105A3 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
10/15/1998 | WO1998027963A3 Gel composition and methods |
10/15/1998 | DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances |
10/15/1998 | DE19715478A1 Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen Cosmetic and dermatological compositions based on hard magnetic particles |
10/15/1998 | DE19715477A1 Production of barium and/or strontium hexa:ferrite magnetic particles |
10/15/1998 | CA2287084A1 Diagnosis method and reagents |
10/15/1998 | CA2286739A1 Improved methods of delivery using cationic lipids and helper lipids |
10/15/1998 | CA2285900A1 Prophylactics and remedies for renal diseases |
10/15/1998 | CA2285216A1 Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin |
10/15/1998 | CA2284708A1 Cosmetic and dermatological agent with a hard-magnetic particle base |
10/15/1998 | CA2284625A1 Adhesive for percutaneously absorbable patch and percutaneously absorbable patch |
10/14/1998 | EP0871001A2 Method and apparatus for producing frozen particles using an entrapment zone of atomized cryogenic liquid droplets |
10/14/1998 | EP0870781A1 Blockcopolymers and their use as polymeric surfactants |
10/14/1998 | EP0870540A2 Use of an encapsulated bioactive composition |
10/14/1998 | EP0870499A1 Oral use of (+)-0-Demethyltramadol as analgesic |
10/14/1998 | EP0870498A1 Pharmaceutical, cosmetic or dermo-pharmaceutical path for the delivery of a multitude of different active compounds |
10/14/1998 | EP0870497A1 Aerosol preparation |
10/14/1998 | EP0869986A1 Polymers with controlled physical state and bioerodibility |
10/14/1998 | EP0869937A1 Novel amide-based cationic lipids |
10/14/1998 | EP0869847A1 Electrostatic coating |